Periodic Reporting for period 1 - MAGNOSTICS (Biomimetic MAGnetic nanoparticles with homotypic targeting for combinatorial theraNOSTICS of triple-negative breast cancers)

MAGNOSTICS aimed at developing biomimetic platform for the targeted delivery of siRNA against ABCB1 gene and anti-cancer drug to achieve a multi-modal thernaostics for triple negative breast cancer (TNBC). Metastatic TNBCs are aggressive tumors with poor prognosis contributing...